INSP250117P115000
- 0.40
- 0.000.00%
Inspire Medical Systems Newsroom
RBC Capital Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Maintains Target Price $260
Why Inspire Medical Systems (INSP) Is a Top Momentum Stock for the Long-Term
Inspire Medical Systems, Inc. to Report Fourth Quarter and Fiscal 2024 Financial Results on February 10, 2025
BofA Securities Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Maintains Target Price $255
Analysts Offer Insights on Healthcare Companies: Exact Sciences (EXAS), Denali Therapeutics (DNLI) and Inspire Medical Systems (INSP)
Oppenheimer Maintains Inspire Medical Systems(INSP.US) With Hold Rating
Earnings Week Ahead: TLRY, WBA, DAL, STZ, CALM and More
Inspire Medical Systems, Inc. to Present at 43rd Annual J.P. Morgan Healthcare Conference
Hold Rating on Inspire Medical Systems Amid FDA Approval of Tirzepatide for OSA
The Price Is Right For Inspire Medical Systems, Inc. (NYSE:INSP)
Inspire Medical Systems' (NYSE:INSP) Returns On Capital Are Heading Higher
Express News | Resmed Shares Down 4% and Inspire Medical Systems Shares Fall 2.7% in Early Trading
Express News | Shares of Sleep Apnea Device Makers Resmed and Inspire Medical Systems Fall After US FDA Approves Eli Lilly's Weight-Loss Drug to Treat Sleep Apnea
Coupa Announces Inspire May 12-15 and Inspire World Tour Roadshow
Wells Fargo Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Maintains Target Price $198
Inspire Medical Systems: Balancing Growth Prospects and Market Challenges – A Hold Rating by Larry Biegelsen
Presidio Medical Announces Appointment of Richard J. Buchholz to Join Its Board of Directors
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Express News | Inspire Medical Systems Inc : Leerink Partners Cuts Target Price to $193 From $197
Sector Update: Health Care Stocks Advance Late Afternoon